'From Five Minutes Of Agony, It's Now Just Seconds,' Says Brazilian Mother Celebrating Free Access To Her Child's Life-Saving CBD Medicine
Portfolio Pulse from Nina Zdinjak
In 2023, São Paulo enacted a law allowing free access to CBD-based medicines, benefiting children with severe epilepsy. This reform was driven by Brazilian mothers advocating for their children's health. Jazz Pharmaceuticals' Epidiolex, an FDA-approved CBD medication, is highlighted as a significant development in treating epilepsy.
August 28, 2024 | 1:11 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jazz Pharmaceuticals' Epidiolex, an FDA-approved CBD medication, is highlighted as a significant development in treating epilepsy, aligning with São Paulo's new law for free CBD access.
The article highlights Epidiolex, Jazz Pharmaceuticals' CBD medication, as a significant treatment for epilepsy, aligning with São Paulo's new law for free CBD access. This positive mention could boost investor confidence in Jazz Pharmaceuticals.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80